Find News

Filter articles

Showing 61 to 70 of 3962 results

US govt seeks new trial in Gilead HIV drug patent case

US18-05-2023Muireann Bolger

The government lost its high stakes and unusual royalties dispute with the big pharma firm | New status report claims that the court should have allowed the jury to take four inter partes petitions into account.

FTC sues to bar Amgen from major IP $28bn acquisition

US18-05-2023Muireann Bolger

The $27.8 billion acquisition would allegedly enable the pharma giant to stifle competition for thyroid eye disease and chronic refractory gout treatments | There is currently no market competition for the treatments.

Teva loses plea against GSK’s $235m ‘skinny label’ win

16-05-2023Sarah Speight

The US Supreme Court knocks back Teva’s challenge to GSK’s damages win | Decision issued despite US solicitor general warning that the earlier decision ‘threatens significant harm’ to the market.

LabCorp hit with further $100m in DNA test patent case

16-05-2023Muireann Bolger

Judge Albright awards punitive damages due to the 'intentional' nature of the infringement | Ravgen fails to secure a three-fold increase on damages awarded by a US jury last year.

Teva and Apotex prevail in sleep drug dispute

US11-05-2023Muireann Bolger

The dispute centred on a treatment that helps people adjust their circadian rhythm | Path now clear for generic drug makers to unveil biosimilar versions of the drug.

Gilead defeats US govt in billion-dollar HIV drug patent suit

US11-05-2023Liz Hockley

Jury finds three US government patents over PrEP to be invalid | Case thought to be the first time US government has sued a pharmaceutical firm over patents.

BMS loses UK appeal over blood-thinning drug

UK09-05-2023Legal developmentsLiz Hockley

Decision addresses issue of plausibility in invalidation verdict | Case marks first time that Court of Appeal judges held a patent with a single claim to a pharma compound invalid.

AWA promotes female patent attorney to group CEO

09-05-2023Sarah Speight

The new CEO is currently Denmark CEO and group VP for the firm, who has ‘spearheaded international growth efforts’.

Amgen sues generic drug maker over bone treatments

US04-05-2023Legal developmentsMuireann Bolger

Lawsuit concerns multibillion-dollar bone-strengthening drugs | Alleged dearth of information provided to patent owner before biologics licence application was approved.

Vizgen accuses Harvard and 10x of patent licence cover-up

US04-05-2023Legal developmentsLiz Hockley

Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

Showing 61 to 70 of 3962 results